ask="N/A"
ask_size="N/A"
average_daily_volume="387563"
bid="6.75"
bid_size="10000"
book_value="3.69"
change="+0.15"
change_from_200_day_moving_average="-2.36"
change_from_50_day_moving_average="0.02"
change_from_52_week_high="-6.45"
change_From_52_week_low="4.09"
change_in_percent="+1.87%"
close="8.15"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.17"
ebitda="-38.95M"
eps_estimate_current_year="-2.14"
eps_estimate_next_quarter="-0.51"
eps_estimate_next_year="-1.95"
ex_dividend_date="N/A"
float_shares="16088000"
high="8.30"
high_52_weeks="14.60"
last_trade_date="3/8/2017"
last_trade_price="8.15"
last_trade_size="9668"
last_trade_time="4:00pm"
low="8.05"
low_52_weeks="4.06"
market_capitalization="145.44M"
moving_average_200_day="10.51"
moving_average_50_day="8.13"
name="Stemline Therapeutics
Inc."
notes="N/A"
one_year_target_price="25.50"
open="8.20"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-22.46%"
percent_change_from_50_day_moving_average="+0.23%"
percent_change_from_52_week_high="-44.18%"
percent_change_from_52_week_low="+100.79%"
previous_close="8.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.17"
price_per_sales="150.66"
revenue="947604.00"
shares_outstanding="17846000"
short_ratio="1.42"
stock_exchange="NCM"
symbol="STML"
volume="208037"
weeks_range_52="4.06 - 14.60"
